Literature DB >> 1774328

Application of an indirect immunofluorescence test for detection of Mycoplasma pneumoniae in respiratory exudates.

Y Hirai1, J Shiode, T Masayoshi, Y Kanemasa.   

Abstract

We prepared polyclonal antibody specific to Mycoplasma pneumoniae and examined the conditions influencing the ability of an indirect immunofluorescence test to detect the specific antigen in respiratory exudates. The antibody did not cross-react with normal human serum or with respiratory exudates from 10 healthy persons. Cross-reactivity of the antibody with species of mycoplasmas other than M. genitalium was fully diminished when absorbed with horse serum and yeast extract, components of the culture medium. Though the absorbed antibody cross-reacted with M. genitalium, the titer was significantly lower than when tested against M. pneumoniae. Two types of antigen-specific fluorescence were observed in clinical specimens: one is large or small fluorescent granular aggregates found in mucus, and the other is fine fluorescent particles diffused on the entire surface of small epithelial cells. Throat smears from 49 patients with serologically confirmed M. pneumoniae infections were examined by our indirect immunofluorescence method. Positive results were obtained in 42 cases, many of which were positive before a rise in serum antibody titer could be demonstrated, indicating that the method is useful for a preliminary diagnosis at an early stage of the infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774328      PMCID: PMC270250          DOI: 10.1128/jcm.29.9.2007-2012.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  MYCOPLASMA SPECIES IDENTIFICATION BASED UPON GROWTH INHIBITION BY SPECIFIC ANTISERA.

Authors:  W A CLYDE
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

2.  Infection with Mycoplasma pneumoniae in civilians in the Netherlands.

Authors:  J F Hers; N Masurel
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

3.  Serologic response to Myocplasma pneumoniae infection. II. Significance of antibody measured by different techniques.

Authors:  D Taylor-Robinson; A Shirai; O Sobĕslavský; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

4.  Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection.

Authors:  D Taylor-Robinson; O Sobĕslavsyý; K E Jensen; L B Senterfit; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

5.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

6.  The serological diagnosis of Mycoplasma pneumoniae infection: a comparison of complement fixation, haemagglutination and immunofluorescence.

Authors:  S A Rousseau; R E Tettmar
Journal:  J Hyg (Lond)       Date:  1985-10

7.  Comparison of Gen-Probe commercial kit and culture technique for the diagnosis of Mycoplasma pneumoniae infection.

Authors:  R Dular; R Kajioka; S Kasatiya
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

8.  Laboratory diagnosis of Mycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay.

Authors:  T W Kok; G Varkanis; B P Marmion; J Martin; A Esterman
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

9.  Comparative studies of three serologic methods for the measurement of Mycoplasma pneumoniae antibodies.

Authors:  S H Lee; S Charoenying; T Brennan; M Markowski; D R Mayo
Journal:  Am J Clin Pathol       Date:  1989-09       Impact factor: 2.493

10.  Laboratory diagnosis of Mycoplasma pneumoniae infection. 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates.

Authors:  R Harris; B P Marmion; G Varkanis; T Kok; B Lunn; J Martin
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

View more
  4 in total

1.  Mycoplasma agassizii strain variation and distinct host antibody responses explain differences between enzyme-linked immunosorbent assays and Western blot assays.

Authors:  Lori D Wendland; Paul A Klein; Elliott R Jacobson; Mary B Brown
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

2.  Evaluation of an antigen-capture enzyme immunoassay for rapid diagnosis of Mycoplasma pneumoniae infection.

Authors:  M Kleemola; R Räty; J Karjalainen; W Schuy; B Gerstenecker; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

Review 3.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel.

Authors:  M Ben-Yaakov; Z Lazarovich; S Beer; A Levin; I Shoham; I Boldur
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.